Stacie S. Aarestad

Partner, Co-Chair, Capital Markets Practice - Boston

Stacie Aarestad
Download Media Photo

Contact Information

617.832.1108

617.832.7000

saarestad@foleyhoag.com Download vCard

Stacie Aarestad is a partner at Foley Hoag and Co-Chair of the firm's Capital Markets Practice. She focuses on corporate and securities law matters, public company representation and merger and acquisition transactions. Stacie represents issuers in a broad range of capital market transactions, including public and private offerings of debt and equity securities, and also advises companies with respect to tender offers, exchange offers, debt repurchases and stock buybacks.

More »

Education:

  • Boston University School of Law, J.D., magna cum laude, 1997
  • Colgate University, B.A., magna cum laude, Phi Beta Kappa, 1991

Languages:

English

Representative Experience

  • Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) in its initial public offering of common stock
  • Zosano Pharma Corporation (NASDAQ:  ZSAN) $29.3 million underwritten public offering of common stock
  • Zosano Pharma $7.5 million PIPE of units (common stock and warrants) with warrants exercisable for an additional $14.4 million
  • Dyax Corp. (NASDAQ: DYAX) in its sale to Shire plc.
  • Dyax Corp. in public securities offerings including:
    • $230,000,000 underwritten public offering of common stock
    • $80,000,000 underwritten public offering of common stock
    • $65,000,000 underwritten public offering of common stock
    • $30,000,000 registered direct offering of common stock
    • $63,537,500 underwritten public offering of common stock
    • $21,000,000 underwritten public offering of common stock
    • $17,250,000 underwritten public offering of common stock
    • $50,000,000 Committed Equity Financing Facility with Azimuth Opportunity Ltd.
    • $44,300,000 underwritten public offering of common stock
  • Dyax Corp. in connection with secured loans including:
    • $65,000,000 loan agreement with Cowen Healthcare Royalty Partners, L.P., consisting of a $50,000,000 Tranche A loan and a $15,000,000 Tranche B loan, secured by Dyax’s phage display Licensing and Funded Research Program
    • $30,000,000 royalty interest assignment agreement with Paul Capital Partners
  • Bolt Technology Corporation (NASDAQ: BOLT) in its sale to Teledyne Technologies Incorporated (NYSE: TDY)
  • NewStar Financial, Inc. (NASDAQ: NEWS) in securities offerings:
    • $300,000,000 144A offering of 7.25% Senior Notes due 2020
    • $125,000,000 PIPE with institutional investors including, Corsair Capital, Union Square Partners and Och-Ziff Capital Management, Swiss Re and SAB Capital
  • Lamar Advertising Company (NASDAQ: LAMR) in its REIT conversion
  • Lamar Advertising Company and its wholly owned subsidiary Lamar Media Corp. in high yield and convertible debt offerings and tender offers including:
    • $400,000,000 144A offering of 5 3/4% Senior Notes due 2026
    • $510,000,000 144A offering of 5 ⅜% Senior Notes due 2024 with follow-on exchange offer
    • $535,000,000 144A offering of 5% Senior Subordinated Notes due 2023 with follow-on exchange offer
    • $500,000,000 144A offering of 5 ⅞% Senior Subordinated Notes due 2022 with follow-on exchange offer
    • $400,000,000 144A offering of 7 ⅞% Senior Subordinated Notes due 2018 with follow-on exchange offer
    • Cash Tender Offer and Consent Solicitation for all of Lamar’s then outstanding 7 ¼% Senior Subordinated Notes due 2013
    • Tender Offer to eligible employees and directors to exchange certain outstanding options to purchase the Company's Class A common stock for a lesser number of new options
    • Cash Tender Offers for all of Lamar’s then outstanding 2 ⅞% Convertible Notes due 2010—Series B
    • $350,000,000 144A offering of 9 ¾% Senior Notes due 2014 with follow-on exchange offer
    • $275,000,000 144A offering of 6 ⅝% Senior Subordinated Notes due 2015—Series C with follow-on exchange offer
    • Exchange Offer of a new series of 2 ⅞% Convertible Notes due 2010—Series B for all outstanding 2 ⅞% Convertible Notes due 2010
    • $216,000,000 144A offering of 6 ⅝% Senior Subordinated Notes due 2015—Series B with follow-on exchange offer
    • $400,000,000 144A offering of 6 ⅝% Senior Subordinated Notes due 2015 with follow-on exchange offer

Honors

  • "Top Women of Law," Massachusetts Lawyers Weekly, 2014
  • Selected for the Greater Boston Chamber of Commerce’s Executive Leadership Institute, 2014
  • Articles Editor, Boston University Law Review
  • Albert P. Pettoruto Memorial Award

Involvement

  • Member, American Bar Association
  • Member, Massachusetts Bar Association
  • Member, Boston Bar Association
  • Member, Board of Directors, Massachusetts Biotechnology Education Foundation, Inc. (MassBioEd)
Add to Bio Folder

Download Bio

Bar Admissions

  • Massachusetts